Trials / Completed
CompletedNCT01155401
Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine and analyse the incidence, severity, risk factors and routine management of acute drug-induced upper gastrointestinal bleeding (UGIB) in the population of Russian patients
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-07-01
- Last updated
- 2011-11-08
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01155401. Inclusion in this directory is not an endorsement.